Belgium· BE-AMP-SAM533413-00

Carmustine Medac 100 mg

A carmustine product containing carmustine, registered in Belgium by Medac. The same ATC class is registered in 16 of our 19 countries.

ATC L01AD01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about carmustineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Carmustine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AD01 (carmustine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search carmustine products by name

Carmustine · ATC L01AD01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Carmustine
Manufacturer: Medac
Country: Belgium (BE)
ATC code: L01AD01
ATC class: Carmustine
Defined daily dose: 8.57 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
2379857

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for carmustine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check carmustine against other medicines How interaction checks work

Carmustine · interactions on record

253 records

36 severe
108 moderate
15 minor
94 info

Most severe, free to view

CimetidineA02BA01severe
MipomersenC10AX11severe
LomitapideC10AX12severe
Nalidixic acidJ01MB02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carmustine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carmustine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Carmubris®, Carmustin Accord
Cyprus · Carmustine Accord, Carmustine Msn
Czechia · Carmustine Accord, Carmustine Msn
Germany · Carmubris, Carmustin Accord
Denmark · Carmustin Waymade, Carmustine Accord
Estonia · Carmustine Accord
Spain · Bicnu, Carmustina Accord
Finland · Carmustine Accord, Carmustine Accordpharma
France · Bicnu, Carmustine Accord
United Kingdom (Northern Ireland) · Carmustine Accord, Carmustine Accord Healthcare
Greece · Carmustine Tillomed, Carmustine Waymade
Croatia · Karmustin Msn, Karmustin Pliva
Hungary · Carmustine Teva, Carmustine Tillomed
Ireland · Carmustine Accord, Carmustine Accord Healthcare Ireland
Iceland · Carmustine Medac, Carmustine Stada
Italy · Bicnu, Carmustina Hikma
Liechtenstein · Carmustin Medac
Lithuania · Carmustine Zentiva
Malta · Carmustine Dr. Reddys
Netherlands · Carmustine Accord, Carmustine Glenmark
Norway · Carmustine, Carmustine Accord
Poland · Carmustine Accord, Carmustine Accordpharma
Portugal · Carmustina Accord, Carmustina Accordpharma
Romania · Carmustină Waymade
Sweden · Carmustine, Carmustine Accord
Slovenia · Karmustin Teva, Karmustin Tillomed Pharma
Slovakia · Carmustine Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/1416424b-6d97-4197-a804-a48f51316de5
GET /v1/drugs/1416424b-6d97-4197-a804-a48f51316de5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Carmustine Medac 100 mg",
  "name_fr": "Carmustine Medac 100 mg",
  "name_nl": "Carmustine Medac 100 mg",
  "amp_code": "SAM533413-00",
  "strengths": [
    "100.0000",
    "100.0000",
    "100.0000",
    "3.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Carmustine",
    "Anhydrous Ethanol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Carmustine",
  "authorisation_numbers": [
    "EU/1/18/1278/001"
  ]
}

API reference MCP server Plans

See everything about carmustine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console